Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

APPG calls on minister to end commissioning barrier

The all party pharmacy group (APPG) has called for an overhaul of pharmacy commissioning to end the "real barrier" in delivering services to patients.

In a letter to pharmacy minister Earl Howe, APPG chair Kevin Barron called on the government to ensure commissioning reflects pharmacy’s role in improving public health and remove the “variability” of commissioning and funding across the UK.


The calls comes ahead of a public health white paper, which is expected to be published next month (December).

Pharmacy has “come a long way” in demonstrating its capability, Mr Barron said, adding that there is cross-party consensus on “the important role pharmacy can and should play in delivering public health”. However, commissioning still presented "a real barrier".

“In future we need to see GP consortia, local authorities and the national commissioning board working in partnership with pharmacy to capitalise fully on its capability public health,” Mr Barron added.

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD013426

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel